Standard Biotools | FLDM - Current Liabilities

Stock Price
0.98
Daily Change
-0.01 -1.49%
Monthly
6.61%
Yearly
-8.81%
Q2 Forecast
0.97

Standard Biotools reported $42.2M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Danaher USD 7.46B 653M Mar/2026
Illumina USD 1.57B 19M Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
Nikon Corporation JPY 328.3B 40.08B Mar/2026
Pacific Biosciences Of California USD 65.36M 7.48M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sony JPY 5.03T 126.26B Mar/2026
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025